Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1
Abstract Psoriasis is a common inflammatory disease of especially high recurrence rate (90%) which is suffered by approximately 3% of the world population. The overexpression of reactive oxygen species (ROS) plays a critical role in psoriasis progress. Here we show that biomimetic iron single-atom c...
Main Authors: | Xiangyu Lu, Le Kuai, Fang Huang, Jingsi Jiang, Jiankun Song, Yiqiong Liu, Si Chen, Lijie Mao, Wei Peng, Ying Luo, Yongyong Li, Haiqing Dong, Bin Li, Jianlin Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-42477-y |
Similar Items
-
The Relapse of Psoriasis: Mechanisms and Mysteries
by: Danning Tian, et al.
Published: (2022-05-01) -
Impact of ROS-Dependent Lipid Metabolism on Psoriasis Pathophysiology
by: Adam Wroński, et al.
Published: (2022-10-01) -
Restoration of IL-11 and IL-15 cytokine production post calcium modulators and ROS treatment can assist viral clearance both in vitro and in vivo
by: Kehkshan Jabeen, et al.
Published: (2023-02-01) -
Psoriasis clearance rates with different treatments – An In-depth retrospective chart review
by: Katie Lovell, et al.
Published: (2023-01-01) -
What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments
by: Angelyn O. Fairchild, et al.
Published: (2017-11-01)